Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Asset Writedowns and Impairment: 2010-2025

Historic Asset Writedowns and Impairment for Exponent (EXPO) over the last 13 years, with Jan 2025 value amounting to $4.5 million.

  • Exponent's Asset Writedowns and Impairment rose 93.47% to $1.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $3.4 million, marking a year-over-year decrease of 23.51%. This contributed to the annual value of $4.5 million for FY2025, which is 37.98% up from last year.
  • Exponent's Asset Writedowns and Impairment amounted to $4.5 million in FY2025, which was up 37.98% from $3.2 million recorded in FY2023.
  • Exponent's 5-year Asset Writedowns and Impairment high stood at $4.5 million for FY2025, and its period low was $1.8 million during FY2021.
  • Over the past 2 years, Exponent's median Asset Writedowns and Impairment value was $3.8 million (recorded in 2023), while the average stood at $3.8 million.
  • As far as peak fluctuations go, Exponent's Asset Writedowns and Impairment dropped by 16.86% in 2021, and later surged by 57.35% in 2022.
  • Over the past 4 years, Exponent's Asset Writedowns and Impairment (Yearly) stood at $1.8 million in 2021, then increased by 5.90% to $2.0 million in 2021, then skyrocketed by 57.35% to $3.1 million in 2022, then climbed by 4.67% to $3.2 million in 2023, then skyrocketed by 37.98% to $4.5 million in 2025.